GlassScriptPhysician profile
Armando E Hernandez-Rey
NPI 1598723306
$28,263.75
in general payments reported to CMS, 2019-2025
19 companies · $603 in 2025
The $603 reported for 2025 was more than what 89% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $7,709 · 2021: $6,207 · 2022: $649 · 2023: $847 · 2024: $337 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,786.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23,684.00 | 2019-2023 | |
| Ferring Pharmaceuticals INC. | $2,279.30 | 2019-2025 | Menopur |
| Hologic Sales and Service, LLC | $767.58 | 2021-2025 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Myriad Women'S Health, INC. | $443.75 | 2023 | Myrisk |
| Coopersurgical, INC. | $196.95 | 2019-2021 | |
| Astellas Pharma US INC | $127.45 | 2025 | Veozah |
| Emd Serono, INC. | $113.29 | 2019-2025 | |
| Myovant Sciences INC. | $102.54 | 2021-2022 | |
| Astellas Pharma Global Development | $101.60 | 2025 | Veozah |
| Intuitive Surgical, INC. | $97.37 | 2023 | Da Vinci Surgical System |
| Janssen Pharmaceuticals, INC | $88.71 | 2019 | |
| Meditrina | $52.57 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $46.99 | 2023-2025 | Myfembree, Gemtesa |
| Galen US INC | $33.72 | 2020 | |
| Duchesnay USA Incorporated | $32.89 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $32.74 | 2019 | |
| Pfizer INC. | $28.71 | 2023 | |
| Covidien LP | $17.21 | 2019 | |
| Hamilton Thorne, INC. | $16.38 | 2025 | Lenshooke Semen Quality Analyzer, Guardia, Lykos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Hernandez-Rey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.